Hepatic Cirrhosis
📧 Sign up to get email alerts when something new happens for Hepatic Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis. [Phase 2]
Phase 2 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD2389 in participants with liver fibrosis and com…
-
FDA approval · 2025-12-22FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc.)
The FDA approved a supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) from scPharmaceuticals Inc.
-
FDA approval · 2025-11-14FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for Aldactone (spironolactone) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2025-10-07FDA Approved: LASIX ONYU — Original Application (SQ Innovation, Inc.)
FDA approves LASIX ONYU for the same active ingredient furosemide under an Original Application by SQ Innovation, Inc. The product is now au…
-
FDA approval · 2025-08-06FDA Approved: FUROSEMIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic diuretic furosemide from Meitheal Pharmaceuticals Inc. under ANDA 212803.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-25FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic spironolactone under an original application (ANDA 217761).
-
FDA approval · 2024-11-06FDA Approved: METOLAZONE — Original Application (Micro Labs Limited)
The FDA approved the generic METOLAZONE from Micro Labs Limited under an Original Application. This metolazone product is a thiazide-like di…
-
FDA approval · 2024-09-17FDA Approved: BUMETANIDE — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' bumetanide original application, granting a generic diuretic for edema associated with congestive he…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia [Phase 3]
Phase 3 trial evaluating OsrHSA for efficacy and safety in patients with hepatic cirrhosis and hypoalbuminemia has completed.
-
FDA approval · 2023-07-24FDA Approved: BUMETANIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original ANDA for bumetanide, a loop diuretic used to treat edema and related conditions.
-
FDA approval · 2023-04-20FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide by Mylan Pharmaceuticals Inc., potentially updating label…
-
FDA approval · 2022-10-25FDA Approved: METOLAZONE — Original Application (Aarkish Pharmaceuticals NJ Inc.)
FDA approved the original application for metolazone from Aarkish Pharmaceuticals NJ Inc., granting clearance to manufacture and market a ge…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]
Phase 2 trial of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis (NASH) and liver cirrhosis has completed wit…
-
FDA approval · 2022-08-31FDA Approved: FUROSEMIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for furosemide from Hospira, Inc.
-
FDA approval · 2022-07-06FDA Approved: TRIAMTERENE — Original Application (Biocon Pharma Inc.)
The FDA approved Biocon Pharma Inc.'s original ANDA for Triamterene, granting generic approval to market Triamterene.
-
FDA approval · 2022-05-26FDA Approved: BUMETANIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved Glenmark Pharmaceuticals USA's Original Application for bumetanide, authorizing the generic diuretic bumetanide for U.S. use.
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C [Phase 2]
Phase 2 trial update for BMS-986263 in adults with advanced hepatic fibrosis after curing hepatitis C; study completed with results posted i…
-
FDA approval · 2021-08-20FDA Approved: METOLAZONE — Original Application (Advagen Pharma Limited)
FDA approved Advagen Pharma Limited's Original Application for METOLAZONE, granting approval of a generic diuretic.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) [Phase 2]
Phase 2 trial update for MNK6106 in hepatic cirrhosis with hepatic encephalopathy (HE) has completed with results posted.
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves the original ANDA for Metolazone from Unichem Pharmaceuticals (USA), Inc., establishing its generic status.
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Method Pharmaceuticals, LLC)
FDA approved METOLAZONE under an original ANDA from Method Pharmaceuticals, LLC (generic approval).
-
FDA approval · 2021-02-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide by Prasco Laboratories, authorizing its marketing as …
-
FDA approval · 2020-04-06FDA Approved: BUMETANIDE — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc's supplemental application for bumetanide (generic) under an ANDA.
-
FDA approval · 2019-12-12FDA Approved: BUMETANIDE — Original Application (Rising Pharma Holdings, Inc)
FDA approved an original ANDA for bumetanide from Rising Pharma Holdings, Inc, making the generic diuretic available.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV [Phase 2]
Phase 2 trial of IDN-6556 in post-orthotopic liver transplant patients with chronic hepatitis C-related liver disease has completed with res…